Search research articles
Contact Us
Filters
Showing results (71-80 of 122) with videos related to
Page
of 13
Sort By:
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Blood Advances
|
June 12, 2023
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
Diego Villa, Aixiang Jiang, Carlo Visco, et al.
Blood
|
April 2, 2014
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
Chan Y Cheah, Kate Burbury, Jane F Apperley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
Michael Wang, David Salek, David Belada, et al.
Leukemia & Lymphoma
|
November 6, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
Daniel Fasser, Greta Joy, Mark R Dowling, et al.
British Journal of Haematology
|
July 6, 2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma
Dai Chihara, Jason R Westin, Roberto N Miranda, et al.
Blood
|
June 11, 2024
Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial
Lindsey E Roeker, Jennifer A Woyach, Chan Y Cheah, et al.
Ejhaem
|
April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
Briony Shaw, Eliza Chung, Cameron Wellard, et al.
Annals of Hematology
|
February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Yasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.
Haematologica
|
March 7, 2024
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 122) with videos related to
Sort By:
Page
of 13
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Blood Advances
|
June 12, 2023
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
Diego Villa, Aixiang Jiang, Carlo Visco, et al.
Blood
|
April 2, 2014
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
Chan Y Cheah, Kate Burbury, Jane F Apperley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
Michael Wang, David Salek, David Belada, et al.
Leukemia & Lymphoma
|
November 6, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
Daniel Fasser, Greta Joy, Mark R Dowling, et al.
British Journal of Haematology
|
July 6, 2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma
Dai Chihara, Jason R Westin, Roberto N Miranda, et al.
Blood
|
June 11, 2024
Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial
Lindsey E Roeker, Jennifer A Woyach, Chan Y Cheah, et al.
Ejhaem
|
April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
Briony Shaw, Eliza Chung, Cameron Wellard, et al.
Annals of Hematology
|
February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Yasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.
Haematologica
|
March 7, 2024
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, et al.
Page
of 13